Vivani Medical (VANI) Competitors $1.26 -0.01 (-0.79%) Closing price 04:00 PM EasternExtended Trading$1.28 +0.02 (+1.59%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VANI vs. TMCI, BFLY, RXST, STIM, SNWV, CLPT, TCMD, CATX, NPCE, and NNOXShould you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Treace Medical Concepts (TMCI), Butterfly Network (BFLY), RxSight (RXST), Neuronetics (STIM), Sanuwave Health (SNWV), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Perspective Therapeutics (CATX), NeuroPace (NPCE), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Vivani Medical vs. Its Competitors Treace Medical Concepts Butterfly Network RxSight Neuronetics Sanuwave Health ClearPoint Neuro Tactile Systems Technology Perspective Therapeutics NeuroPace Nano-X Imaging Treace Medical Concepts (NASDAQ:TMCI) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Does the media refer more to TMCI or VANI? In the previous week, Treace Medical Concepts had 18 more articles in the media than Vivani Medical. MarketBeat recorded 19 mentions for Treace Medical Concepts and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.94 beat Treace Medical Concepts' score of 0.23 indicating that Vivani Medical is being referred to more favorably in the news media. Company Overall Sentiment Treace Medical Concepts Neutral Vivani Medical Positive Which has higher earnings & valuation, TMCI or VANI? Vivani Medical has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M2.08-$55.74M-$0.79-8.73Vivani MedicalN/AN/A-$23.49M-$0.43-2.93 Which has more volatility & risk, TMCI or VANI? Treace Medical Concepts has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.99, indicating that its stock price is 199% more volatile than the S&P 500. Is TMCI or VANI more profitable? Vivani Medical has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -23.01%. Treace Medical Concepts' return on equity of -46.76% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-23.01% -46.76% -23.35% Vivani Medical N/A -133.07%-56.50% Do analysts recommend TMCI or VANI? Treace Medical Concepts currently has a consensus target price of $9.83, indicating a potential upside of 42.51%. Vivani Medical has a consensus target price of $4.00, indicating a potential upside of 217.46%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts plainly believe Vivani Medical is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of TMCI or VANI? 84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 27.7% of Treace Medical Concepts shares are held by insiders. Comparatively, 46.4% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryVivani Medical beats Treace Medical Concepts on 9 of the 15 factors compared between the two stocks. Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VANI vs. The Competition Export to ExcelMetricVivani MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.64M$2.47B$5.63B$9.82BDividend YieldN/A1.81%4.64%4.14%P/E Ratio-2.9321.9030.0525.76Price / SalesN/A716.35461.28171.93Price / CashN/A186.7137.7258.50Price / Book4.204.468.476.07Net Income-$23.49M$31.61M$3.26B$265.11M7 Day Performance-9.35%2.94%3.53%2.90%1 Month Performance-10.00%4.27%5.94%3.98%1 Year Performance8.62%7.67%42.73%26.94% Vivani Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VANIVivani Medical2.9187 of 5 stars$1.26-0.8%$4.00+217.5%+9.5%$74.64MN/A-2.9320TMCITreace Medical Concepts2.2557 of 5 stars$5.59-0.4%$10.52+88.1%+14.8%$351.56M$209.36M-6.58250Earnings ReportBFLYButterfly Network2.1939 of 5 stars$1.35-5.9%$3.50+160.2%+45.8%$332.61M$82.06M-4.80460RXSTRxSight2.2694 of 5 stars$7.65-3.4%$17.50+128.8%-85.9%$310.90M$139.93M-11.42220Trending NewsEarnings ReportSTIMNeuronetics1.9843 of 5 stars$4.55-2.4%$5.50+20.9%+418.1%$300.80M$74.89M-3.47180Gap DownHigh Trading VolumeSNWVSanuwave Health1.3705 of 5 stars$35.00-1.4%$49.00+40.0%N/A$299.92M$36.19M-7.6840Earnings ReportGap UpCLPTClearPoint Neuro2.2217 of 5 stars$10.53flat$19.67+86.8%+7.8%$294.74M$31.39M-13.86110News CoverageEarnings ReportHigh Trading VolumeTCMDTactile Systems Technology2.0059 of 5 stars$12.54+26.8%$13.50+7.7%-3.1%$291.56M$292.98M19.001,037High Trading VolumeCATXPerspective Therapeutics1.6396 of 5 stars$3.92+0.8%$12.56+220.3%-67.1%$290.97MN/A0.0070News CoverageNPCENeuroPace3.6854 of 5 stars$8.70-2.6%$17.00+95.4%+32.3%$285.36M$79.91M-10.36170Trending NewsEarnings ReportAnalyst ForecastNNOXNano-X Imaging2.5428 of 5 stars$4.89+2.9%$9.50+94.3%-33.9%$282.54M$11.28M-5.43190News CoverageEarnings ReportAnalyst Upgrade Related Companies and Tools Related Companies TMCI Competitors BFLY Competitors RXST Competitors STIM Competitors SNWV Competitors CLPT Competitors TCMD Competitors CATX Competitors NPCE Competitors NNOX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VANI) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access